Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Key Takeaways From This Blog: GLP-1 updates highlight growing use of these medications and their impact on employer health plans
Mantaj J, et al
I love this
Crohn's Disease and GLP-1 Medication Safety Considerations Research on GLP-1 receptor agonists in inflammatory bowel disease is still emerging, but current evidence suggests these medications do not directly promote intestinal inflammation
doi: 10.2147/OTT.S150701 75 AkiyamaSOgiwaraTAokiTTsunekawaKArakiOMurakamiM
US$ 28.89
US$ 24.92
US$ 20.84
US$ 27.37
